Allentown, PA -- (SBWire) -- 05/08/2019 --YMC recently collaborated with C&E News in the publication of a whitepaper detailing the rise of hybrid-silica stationary phases in the pharmaceutical marketplace. The whitepaper is available for free download.
The whitepaper aims to provide pharmaceutical researchers a better understanding of the uses and benefits of hybrid silica-based supports in HPLC separations of drug compounds.
The use of hybrid silica-based stationary phases for HPLC has seen growing interest in pharmaceutical research, due to the underlying properties of the base material. The whitepaper includes commentary from a number of experts in the field, helping readers discover how hybrid silica-based chromatography rose to popularity in the pharma lab, and why.
Hybrid silica and conventional silica are compared to help illustrate the differences in the performance and characteristics of the materials. The many benefits of hybrid silica materials are compared and contrasted with traditional silica usage, supported by references and examples from end users.
For a downloadable copy of the whitepaper, see: http://connect.acspubs.org/YMCAmerica_hybrid_silica_WP?partnerref=CENonline
Read more about YMC Hybrid Materials
https://www.ymcamerica.com/ymc-triart/
Also contact: info@ymcamerica.com; call 888-341-8380.
About YMC America, Inc.
Established in 1980, YMC America, Inc. is worldwide full-service liquid chromatography company, which offers sales, technical product support, service, application assistance, purification services, contract synthesis and method development.
All YMC products are available worldwide through YMC's network of subsidiaries. This worldwide presence as a full-range chromatography supplier ensures that all YMC products are fully available and fully supported both locally and globally.
See: https://www.ymcamerica.com/
YMC Whitepaper Discusses Hybrid-Based Silica Supports for HPLC